Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique. 1977

P J Morrison, and I D Bradbrook, and H J Rogers

1 A quantitative thin layer chromatographic technique for the estimation of plasma prednisolone levels has been devised with a minimum level of estimation of 10 ng/ml. 2 A comparative study of the absorption of 5 and 10 mg prednisolone from enteric and non-enteric coated tablets (5 mg) was carried out in healthy subjects. 3 Mean plasma half-life and peak plasma concentrations obtained from the non-enteric coated preparation agree well with previous studies in normal subjects reported by other investigators using competitive protein binding or radioimmunoassay techniques. Intersubject variability in bioavailability was noted. 4 Enteric coating increased the lag time before prednisolone appeared in the blood but did not alter the bioavailability of prednisolone compared to the equivalent dose of the non-enteric coated tablet.

UI MeSH Term Description Entries
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P J Morrison, and I D Bradbrook, and H J Rogers
August 1975, British journal of clinical pharmacology,
P J Morrison, and I D Bradbrook, and H J Rogers
September 1980, British medical journal,
P J Morrison, and I D Bradbrook, and H J Rogers
May 1979, British journal of clinical pharmacology,
P J Morrison, and I D Bradbrook, and H J Rogers
June 1977, British journal of clinical pharmacology,
P J Morrison, and I D Bradbrook, and H J Rogers
January 1989, European journal of clinical pharmacology,
P J Morrison, and I D Bradbrook, and H J Rogers
May 1992, British journal of clinical pharmacology,
P J Morrison, and I D Bradbrook, and H J Rogers
January 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
P J Morrison, and I D Bradbrook, and H J Rogers
January 1992, European journal of rheumatology and inflammation,
P J Morrison, and I D Bradbrook, and H J Rogers
January 1985, Acta poloniae pharmaceutica,
Copied contents to your clipboard!